1. Home
  2. ETNB vs WOLF Comparison

ETNB vs WOLF Comparison

Compare ETNB & WOLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ETNB
  • WOLF
  • Stock Information
  • Founded
  • ETNB 2018
  • WOLF 1987
  • Country
  • ETNB United States
  • WOLF United States
  • Employees
  • ETNB N/A
  • WOLF N/A
  • Industry
  • ETNB Biotechnology: Pharmaceutical Preparations
  • WOLF Semiconductors
  • Sector
  • ETNB Health Care
  • WOLF Technology
  • Exchange
  • ETNB Nasdaq
  • WOLF Nasdaq
  • Market Cap
  • ETNB 1.0B
  • WOLF 978.5M
  • IPO Year
  • ETNB 2019
  • WOLF 1993
  • Fundamental
  • Price
  • ETNB $10.05
  • WOLF $1.28
  • Analyst Decision
  • ETNB Strong Buy
  • WOLF Hold
  • Analyst Count
  • ETNB 8
  • WOLF 14
  • Target Price
  • ETNB $26.43
  • WOLF $10.67
  • AVG Volume (30 Days)
  • ETNB 2.1M
  • WOLF 50.0M
  • Earning Date
  • ETNB 05-01-2025
  • WOLF 05-08-2025
  • Dividend Yield
  • ETNB N/A
  • WOLF N/A
  • EPS Growth
  • ETNB N/A
  • WOLF N/A
  • EPS
  • ETNB N/A
  • WOLF N/A
  • Revenue
  • ETNB N/A
  • WOLF $761,300,000.00
  • Revenue This Year
  • ETNB N/A
  • WOLF N/A
  • Revenue Next Year
  • ETNB N/A
  • WOLF $14.89
  • P/E Ratio
  • ETNB N/A
  • WOLF N/A
  • Revenue Growth
  • ETNB N/A
  • WOLF N/A
  • 52 Week Low
  • ETNB $4.16
  • WOLF $0.82
  • 52 Week High
  • ETNB $11.84
  • WOLF $30.86
  • Technical
  • Relative Strength Index (RSI)
  • ETNB 68.44
  • WOLF 32.97
  • Support Level
  • ETNB $8.94
  • WOLF $1.33
  • Resistance Level
  • ETNB $9.70
  • WOLF $1.90
  • Average True Range (ATR)
  • ETNB 0.73
  • WOLF 0.37
  • MACD
  • ETNB 0.14
  • WOLF -0.20
  • Stochastic Oscillator
  • ETNB 93.78
  • WOLF 12.94

About ETNB 89bio Inc.

89bio Inc is a United States-based clinical-stage biopharmaceutical company focused on the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases. Its product candidate, pegozafermin (previously BIO89-100), a specifically engineered glycoPEGylated analog of fibroblast growth factor 21 (FGF21), is currently being developed for the treatment of nonalcoholic steatohepatitis (NASH) and for the treatment of severe hypertriglyceridemia (SHTG).

About WOLF Wolfspeed Inc.

Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.

Share on Social Networks: